Search Results - "Hydroxymethylglutaryl-CoA Reductase Inhibitors"

Statin Use Is Associated With a Decline in Muscle Function and Mass Over Time, Irrespective of Statin Pharmacogenomic Score.

Authors: Gentreau M Sakr M Mohammad S et al.

Source: Journal of cachexia, sarcopenia and muscle [J Cachexia Sarcopenia Muscle] 2025 Dec; Vol. 16 (6), pp. e70132.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

MeSH Terms: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology , Muscle, Skeletal*/drug effects , Muscle, Skeletal*/physiopathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Hand Strength ; Cross-Sectional Studies ; Pharmacogenetics

Effect of LDL-Cholesterol Levels and Oral Atorvastatin on Outcomes After Pipeline Therapy for Intracranial Aneurysms.

Authors: Feng X Huang C Tong X et al.

Source: Stroke [Stroke] 2025 Oct; Vol. 56 (10), pp. 3002-3013. Date of Electronic Publication: 2025 Aug 06.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0235266 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4628 (Electronic) Linking ISSN: 00392499 NLM ISO Abbreviation: Stroke Subsets: MEDLINE

MeSH Terms: Atorvastatin*/administration & dosage , Atorvastatin*/therapeutic use , Intracranial Aneurysm*/blood , Intracranial Aneurysm*/therapy , Cholesterol, LDL*/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Embolization, Therapeutic*/methods, Humans ; Female ; Male ; Middle Aged ; Treatment Outcome ; Aged ; Registries ; Adult ; Stents ; Administration, Oral

Utilizing Physiologically Based Pharmacokinetic Modeling and Virtual Simulation for Simvastatin Tablets to Evaluate the Sensitivity of Using Parent vs Metabolite as Analyte on Bioequivalence Assessment.

Authors: Cheng YH Wu F Yoon M et al.

Source: The AAPS journal [AAPS J] 2025 Dec 06; Vol. 28 (1), pp. 29. Date of Electronic Publication: 2025 Dec 06.

Publication Type: Journal Article

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

MeSH Terms: Simvastatin*/pharmacokinetics , Simvastatin*/analogs & derivatives , Simvastatin*/administration & dosage , Models, Biological* , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacokinetics , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage, Humans ; Therapeutic Equivalency ; Tablets ; Computer Simulation ; Adult ; Male ; Young Adult ; Fasting ; Cross-Over Studies ; Female ; Healthy Volunteers

Medication count, including statin or metformin use, is not associated with influenza vaccine responses in older adults.

Authors: Li V McClure H Patel R et al.

Source: Vaccine [Vaccine] 2025 Dec 05; Vol. 68, pp. 127913. Date of Electronic Publication: 2025 Oct 29.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

MeSH Terms: Influenza Vaccines*/immunology , Influenza Vaccines*/administration & dosage , Metformin*/therapeutic use , Metformin*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Influenza, Human*/prevention & control , Influenza, Human*/immunology, Humans ; Aged ; Male ; Female ; Aged, 80 and over ; Antibodies, Viral/blood ; Vaccination

Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer.

Authors: Flanagan S Lis RT Huang Y et al.

Source: Molecular cancer research : MCR [Mol Cancer Res] 2025 Dec 02; Vol. 23 (12), pp. 1025-1033.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

MeSH Terms: Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/metabolism , Prostatic Neoplasms*/mortality , Prostatic Neoplasms*/genetics , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl CoA Reductases*/metabolism , Hydroxymethylglutaryl CoA Reductases*/genetics , Cholesterol*/biosynthesis, Male ; Humans ; Aged ; Middle Aged ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; Prospective Studies

Do the pharmacokinetics of statins explain psychiatric symptom improvement from adjunctive statin prescribing in severe mental illness? Three target trial emulation studies.

Authors: Launders N Richards-Belle A Hardoon S et al.

Source: BMJ mental health [BMJ Ment Health] 2025 Dec 01; Vol. 28 (1), pp. 1-8. Date of Electronic Publication: 2025 Dec 01.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 9918521385306676 Publication Model: Electronic Cited Medium: Internet ISSN: 2755-9734 (Electronic) Linking ISSN: 27559734 NLM ISO Abbreviation: BMJ Ment Health Subsets: MEDLINE

MeSH Terms: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacokinetics , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Antipsychotic Agents*/therapeutic use , Antipsychotic Agents*/pharmacokinetics , Schizophrenia*/drug therapy , Bipolar Disorder*/drug therapy , Mental Disorders*/drug therapy , Psychotic Disorders*/drug therapy, Humans ; Male ; Female ; Adult ; Middle Aged ; Drug Therapy, Combination

Association Between Statin Use and Glaucoma Risk: A Population-Based Study.

Authors: Pan SY Weng CH Tien PT et al.

Source: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2025 Dec 01; Vol. 66 (15), pp. 7.

Publication Type: Journal Article

Journal Info: Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited Medium: Internet ISSN: 1552-5783 (Electronic) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE

MeSH Terms: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Glaucoma, Open-Angle*/epidemiology , Glaucoma, Open-Angle*/chemically induced , Low Tension Glaucoma*/epidemiology , Low Tension Glaucoma*/chemically induced, Humans ; Male ; Female ; Middle Aged ; Case-Control Studies ; Taiwan/epidemiology ; Aged ; Risk Factors ; Intraocular Pressure/physiology ; Hyperlipidemias/drug therapy ; Adult ; Ocular Hypertension/epidemiology ; Ocular Hypertension/chemically induced ; Databases, Factual ; Incidence

Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis.

Authors: Albawa'neh AS Alqasrawi MN Al-Mahayri ZN et al.

Source: Annals of medicine [Ann Med] 2025 Dec; Vol. 57 (1), pp. 2594355. Date of Electronic Publication: 2025 Nov 30.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE

MeSH Terms: Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/chemically induced , Diabetes Mellitus, Type 2*/prevention & control , Ezetimibe*/therapeutic use , Ezetimibe*/adverse effects , Ezetimibe*/administration & dosage , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/adverse effects , Anticholesteremic Agents*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage, Humans ; Drug Therapy, Combination ; Cardiovascular Diseases/prevention & control ; Observational Studies as Topic ; Risk Factors

Statin Treatment Is Associated With a Higher Risk of Carpal Tunnel Syndrome, But not of Ulnar Nerve Entrapment, in Type 2 Diabetes-A Nationwide Register Study.

Authors: Zimmerman M Perez R Merlo J et al.

Source: Clinical therapeutics [Clin Ther] 2025 Dec; Vol. 47 (12), pp. 1097-1103. Date of Electronic Publication: 2025 Nov 11.

Publication Type: Journal Article

Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE

MeSH Terms: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/epidemiology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Carpal Tunnel Syndrome*/epidemiology , Carpal Tunnel Syndrome*/chemically induced , Ulnar Nerve Compression Syndromes*/epidemiology , Ulnar Nerve Compression Syndromes*/chemically induced, Humans ; Male ; Female ; Middle Aged ; Registries ; Sweden/epidemiology ; Aged ; Risk Factors ; Adult

Impact of High-Intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass.

Authors: Lee Y Kang Y Kim JS et al.

Source: The Thoracic and cardiovascular surgeon [Thorac Cardiovasc Surg] 2025 Dec; Vol. 73 (8), pp. 633-638. Date of Electronic Publication: 2024 Oct 24.

Publication Type: Journal Article

Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 7903387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-1902 (Electronic) Linking ISSN: 01716425 NLM ISO Abbreviation: Thorac Cardiovasc Surg Subsets: MEDLINE

MeSH Terms: Atrial Fibrillation*/prevention & control , Atrial Fibrillation*/diagnosis , Atrial Fibrillation*/etiology , Atrial Fibrillation*/epidemiology , Atrial Fibrillation*/physiopathology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Coronary Artery Bypass, Off-Pump*/adverse effects , Coronary Artery Disease*/surgery , Coronary Artery Disease*/diagnosis , Atorvastatin*/administration & dosage , Atorvastatin*/adverse effects , Rosuvastatin Calcium*/administration & dosage , Rosuvastatin Calcium*/adverse effects, Humans ; Male ; Female ; Retrospective Studies ; Aged ; Risk Factors ; Middle Aged ; Treatment Outcome ; Time Factors ; Odds Ratio ; Logistic Models ; Multivariate Analysis ; Chi-Square Distribution

Potential Protective Effect of Statins against High-Grade Squamous Intraepithelial Lesions in Women with Metabolic Comorbidities.

Authors: Gautam P Zhao J Levi C et al.

Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2025 Dec 01; Vol. 34 (12), pp. 2169-2177.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

MeSH Terms: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology , Uterine Cervical Neoplasms*/prevention & control , Uterine Cervical Neoplasms*/epidemiology , Uterine Cervical Neoplasms*/pathology , Squamous Intraepithelial Lesions*/prevention & control , Squamous Intraepithelial Lesions*/pathology , Squamous Intraepithelial Lesions*/epidemiology , Uterine Cervical Dysplasia*/prevention & control , Uterine Cervical Dysplasia*/pathology , Uterine Cervical Dysplasia*/epidemiology, Humans ; Female ; Cross-Sectional Studies ; Middle Aged ; Retrospective Studies ; Comorbidity ; Adult ; Aged

Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting.

Authors: Climente-Martí M García-González X Torres-Bondia FI et al.

Source: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 1857-1868. Date of Electronic Publication: 2025 Oct 25.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

MeSH Terms: Cholesterol, LDL*/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/economics , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Anticholesteremic Agents*/economics , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Dyslipidemias*/drug therapy, Humans ; Cost-Benefit Analysis ; Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Spain ; Male ; Female ; Drug Therapy, Combination ; Cardiovascular Diseases/prevention & control ; Middle Aged ; Secondary Prevention/economics ; Secondary Prevention/methods ; Monte Carlo Method ; Aged ; PCSK9 Inhibitors

Statins and longitudinal changes in vertebral bone mineral density in an emulated target trial: the multi-ethnic study of atherosclerosis.

Authors: Ghotbi E Hathaway QA Hadidchi R et al.

Source: Bone [Bone] 2025 Dec; Vol. 201, pp. 117659. Date of Electronic Publication: 2025 Sep 22.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2763 (Electronic) Linking ISSN: 18732763 NLM ISO Abbreviation: Bone Subsets: MEDLINE

MeSH Terms: Atherosclerosis*/drug therapy , Atherosclerosis*/physiopathology , Atherosclerosis*/ethnology , Bone Density*/drug effects , Ethnicity* , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology , Spine*/drug effects, Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Longitudinal Studies

STAREE-HEART: A randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants.

Authors: Hopper I Marwick TH Wolfe R et al.

Source: American heart journal [Am Heart J] 2025 Dec; Vol. 290, pp. 140-152. Date of Electronic Publication: 2025 Jun 12.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

MeSH Terms: Atorvastatin*/therapeutic use , Atorvastatin*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Aging*/physiology , Aging*/drug effects , Ventricular Function, Left*/drug effects , Ventricular Function, Left*/physiology , Heart Failure*/prevention & control, Humans ; Aged ; Male ; Female ; Double-Blind Method ; Biomarkers/blood ; Echocardiography ; Electrocardiography ; Aged, 80 and over ; Primary Prevention/methods

Assessment of unmet clinical needs and healthcare resource use among statin-treated patients with or at risk of developing atherosclerotic cardiovascular disease.

Authors: Ortiz N Shehata J Smart J et al.

Source: Journal of medical economics [J Med Econ] 2025 Dec; Vol. 28 (1), pp. 1616-1625. Date of Electronic Publication: 2025 Sep 16.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

MeSH Terms: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/economics , Atherosclerosis*/prevention & control , Hypercholesterolemia*/drug therapy , Health Resources*/statistics & numerical data , Health Resources*/economics, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Cholesterol, LDL/blood ; Aged ; Secondary Prevention/economics ; Secondary Prevention/methods ; United States ; Insurance Claim Review ; Adult ; Primary Prevention/economics ; Primary Prevention/methods ; Cardiovascular Diseases/prevention & control

Design, synthesis and biological evaluation of novel dualaction statin conjugates with triglyceride and cholesterol lowering activities.

Authors: Qu Z Liu YC Suo Q et al.

Source: Molecular diversity [Mol Divers] 2025 Dec; Vol. 29 (6), pp. 6227-6241. Date of Electronic Publication: 2025 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: ESCOM Science Publishers Country of Publication: Netherlands NLM ID: 9516534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-501X (Electronic) Linking ISSN: 13811991 NLM ISO Abbreviation: Mol Divers Subsets: MEDLINE

MeSH Terms: Triglycerides*/blood , Triglycerides*/metabolism , Cholesterol*/blood , Cholesterol*/metabolism , Drug Design* , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/chemistry , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/chemical synthesis , Anticholesteremic Agents*/pharmacology , Anticholesteremic Agents*/chemistry , Anticholesteremic Agents*/chemical synthesis, Humans ; Structure-Activity Relationship ; Animals

Impact of statin treatment on postoperative atrial fibrillation in surgical aortic valve replacement.

Authors: Krasniqi L Skovbo JS Hallas J et al.

Source: American heart journal [Am Heart J] 2025 Dec; Vol. 290, pp. 82-92. Date of Electronic Publication: 2025 Jun 13.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

MeSH Terms: Atrial Fibrillation*/epidemiology , Atrial Fibrillation*/etiology , Atrial Fibrillation*/prevention & control , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Heart Valve Prosthesis Implantation*/adverse effects , Postoperative Complications*/epidemiology , Postoperative Complications*/prevention & control , Aortic Valve*/surgery , Aortic Valve Stenosis*/surgery, Humans ; Male ; Female ; Aged ; Denmark/epidemiology ; Middle Aged ; Propensity Score ; Follow-Up Studies ; Risk Factors ; Retrospective Studies ; Dose-Response Relationship, Drug

Optimal medical therapy in patients with reduced left ejection fraction undergoing coronary artery bypass graft surgery.

Authors: Holmdahl AJ Sharif S Birring E et al.

Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2025 Nov 27; Vol. 25 (1), pp. 855. Date of Electronic Publication: 2025 Nov 27.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261 (Electronic) Linking ISSN: 14712261 NLM ISO Abbreviation: BMC Cardiovasc Disord Subsets: MEDLINE

MeSH Terms: Coronary Artery Bypass*/adverse effects , Coronary Artery Bypass*/mortality , Stroke Volume*/drug effects , Ventricular Function, Left*/drug effects , Coronary Artery Disease*/mortality , Coronary Artery Disease*/physiopathology , Coronary Artery Disease*/surgery , Coronary Artery Disease*/diagnostic imaging , Coronary Artery Disease*/diagnosis , Cardiovascular Agents*/therapeutic use , Cardiovascular Agents*/adverse effects , Adrenergic beta-Antagonists*/therapeutic use , Adrenergic beta-Antagonists*/adverse effects , Ventricular Dysfunction, Left*/physiopathology , Ventricular Dysfunction, Left*/mortality , Ventricular Dysfunction, Left*/drug therapy , Ventricular Dysfunction, Left*/diagnosis , Ventricular Dysfunction, Left*/diagnostic imaging , Angiotensin-Converting Enzyme Inhibitors*/therapeutic use , Angiotensin-Converting Enzyme Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects, Humans ; Male ; Female ; Aged ; Middle Aged ; Treatment Outcome ; Time Factors ; Risk Factors ; Registries ; Risk Assessment ; Aspirin/therapeutic use ; Retrospective Studies

Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab.

Authors: Dalbeni A Cattazzo F Vicardi M et al.

Corporate Authors: Dalbeni A Cattazzo F Vicardi M et al.

Source: Scientific reports [Sci Rep] 2025 Nov 23; Vol. 15 (1), pp. 41844. Date of Electronic Publication: 2025 Nov 23.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH Terms: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/drug therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/pathology , Bevacizumab*/administration & dosage , Bevacizumab*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Progression-Free Survival

Intraplaque neovascularization and progression of atherosclerosis: A review of SMI technical assessment and berberine-statin regulatory mechanisms.

Authors: Sun X Wang F

Source: Medicine [Medicine (Baltimore)] 2025 Nov 21; Vol. 104 (47), pp. e46174.

Publication Type: Journal Article; Review

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

MeSH Terms: Berberine*/therapeutic use , Berberine*/pharmacology , Atherosclerosis*/drug therapy , Atherosclerosis*/diagnostic imaging , Atherosclerosis*/pathology , Neovascularization, Pathologic*/diagnostic imaging , Neovascularization, Pathologic*/drug therapy , Neovascularization, Pathologic*/pathology , Plaque, Atherosclerotic*/diagnostic imaging , Plaque, Atherosclerotic*/drug therapy , Plaque, Atherosclerotic*/pathology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology, Humans ; Disease Progression